Quantcast

Entasis Therapeutics to Participate in the BMO 2019 Prescriptions for Success Healthcare Conference

By GlobeNewswire,  June 18, 2019, 04:01:00 PM EDT


WALTHAM, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer of the Company, will participate in a fireside chat at the BMO 2019 Prescriptions for Success Healthcare Conference being held June 25, 2019 in New York.

Details of the presentations are below:
Event:   BMO 2019 Prescriptions for Success Healthcare Conference
Date:   Tuesday, June 25, 2019
Location:   The Mandarin Oriental New York
Time:   3:00 - 3:20 PM ET

Additionally, Dr. Perros will hold 1-on-1 investor meetings at the conference. Investors attending the conference who are interested in meeting with Company management should contact their BMO representatives.

About Entasis

Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis' targeted-design platform has produced a pipeline of product candidates, including ETX2514SUL (targeting A. baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae), and ETX0282CPDP (targeting Enterobacteriaceae infections). Entasis is also using its platform to develop a novel class of antibiotics, non-β-lactam inhibitors of the penicillin-binding proteins (NBPs) (targeting Gram-negative infections). For more information, visit www.entasistx.com.

Entasis Company Contact    

Kyle Dow

Entasis Therapeutics

(781) 810-0114

kyle.dow@entasistx.com

Investor Relations Contacts

Tram Bui / Janhavi Mohite

The Ruth Group

(646) 536-7035 / 7026

tbui@theruthgroup.com

jmohite@theruthgroup.com

Media Contact

Kirsten Thomas

The Ruth Group

(508) 280-6592

kthomas@theruthgroup.com 

Source: Entasis Therapeutics Holdings Inc.

This article appears in: News Headlines

Referenced Stocks: ETTX










Today's Market Activity

NASDAQ 8146.49
-60.75  ▼  0.74%
DJIA 27154.20
-68.77  ▼  0.25%
S&P 500 2976.61
-18.50  ▼  0.62%
Data as of Jul 19, 2019